Skip to main content
Top
Published in: Sleep and Breathing 2/2013

01-05-2013 | Letter to the Editors

Should we routinely screen patients with idiopathic pulmonary fibrosis for nocturnal hypoxemia?

Authors: Georgia Pitsiou, Vasilis Bagalas, Afroditi Boutou, Ioannis Stanopoulos, Paraskevi Argyropoulou-Pataka

Published in: Sleep and Breathing | Issue 2/2013

Login to get access

Excerpt

Dear Editor, …
Literature
1.
go back to reference Mermigkis C, Stagaki E, Tryfon S, Schiza S, Amfilochiou A, Polychronopoulos V, Panagou P, Galanis N, Kallianos A, Mermigkis D, Kopanakis A, Varouchakis G, Kapsimalis F, Bouros D (2010) How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Sleep Breath 14:387–390PubMedCrossRef Mermigkis C, Stagaki E, Tryfon S, Schiza S, Amfilochiou A, Polychronopoulos V, Panagou P, Galanis N, Kallianos A, Mermigkis D, Kopanakis A, Varouchakis G, Kapsimalis F, Bouros D (2010) How common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Sleep Breath 14:387–390PubMedCrossRef
2.
go back to reference Ruhle KH (2010) Commentary on how common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Mermigkis C. et al. Sleep Breath 14:289PubMedCrossRef Ruhle KH (2010) Commentary on how common is sleep-disordered breathing in patients with idiopathic pulmonary fibrosis? Mermigkis C. et al. Sleep Breath 14:289PubMedCrossRef
3.
go back to reference Mermigkis C, Mermigkis D, Varouchakis G, Schiza S (2012) CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea—therapeutic difficulties and dilemmas. Sleep Breath 16:1–3PubMedCrossRef Mermigkis C, Mermigkis D, Varouchakis G, Schiza S (2012) CPAP treatment in patients with idiopathic pulmonary fibrosis and obstructive sleep apnea—therapeutic difficulties and dilemmas. Sleep Breath 16:1–3PubMedCrossRef
4.
go back to reference Rasche K, Orth M (2009) Sleep and breathing in idiopathic pulmonary fibrosis. J Physiol Pharmacol 60(Suppl 5):13–14PubMed Rasche K, Orth M (2009) Sleep and breathing in idiopathic pulmonary fibrosis. J Physiol Pharmacol 60(Suppl 5):13–14PubMed
5.
go back to reference Papakosta D, Pitsiou G, Daniil Z, Dimadi M, Stagaki E, Rapti A, Antoniou K, Tzouvelekis A, Kontakiotis T, Tryfon S, Polychronopoulos V, Bouros D (2011) Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters. Lung 189:391–399PubMedCrossRef Papakosta D, Pitsiou G, Daniil Z, Dimadi M, Stagaki E, Rapti A, Antoniou K, Tzouvelekis A, Kontakiotis T, Tryfon S, Polychronopoulos V, Bouros D (2011) Prevalence of pulmonary hypertension in patients with idiopathic pulmonary fibrosis: correlation with physiological parameters. Lung 189:391–399PubMedCrossRef
6.
go back to reference Pitsiou G, Papakosta D, Bouros D (2011) Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. Respiration 82:294–304PubMedCrossRef Pitsiou G, Papakosta D, Bouros D (2011) Pulmonary hypertension in idiopathic pulmonary fibrosis: a review. Respiration 82:294–304PubMedCrossRef
7.
go back to reference Boutou AK, Pitsiou GG, Trigonis I, Papakosta D, Kontou PK, Chavouzis N, Nakou C, Argyropoulou P, Wasserman K, Stanopoulos I (2011) Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension. Respirology 16:451–458PubMedCrossRef Boutou AK, Pitsiou GG, Trigonis I, Papakosta D, Kontou PK, Chavouzis N, Nakou C, Argyropoulou P, Wasserman K, Stanopoulos I (2011) Exercise capacity in idiopathic pulmonary fibrosis: the effect of pulmonary hypertension. Respirology 16:451–458PubMedCrossRef
8.
go back to reference ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824CrossRef ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183:788–824CrossRef
9.
go back to reference Prisco DL, Sica AL, Talwar A, Narasimhan M, Omonuwa K, Hakimisefat B, Dedopoulos S, Shakir N, Greenberg H (2011) Correlation of pulmonary hypertension severity with metrics of comorbid sleep-disordered breathing. Sleep Breath 15:633–639PubMedCrossRef Prisco DL, Sica AL, Talwar A, Narasimhan M, Omonuwa K, Hakimisefat B, Dedopoulos S, Shakir N, Greenberg H (2011) Correlation of pulmonary hypertension severity with metrics of comorbid sleep-disordered breathing. Sleep Breath 15:633–639PubMedCrossRef
10.
go back to reference Trakada G, Nikolaou E, Pouli A, Tsiamita M, Spiropoulos K (2003) Endothelin-1 levels in interstitial lung disease patients during sleep. Sleep Breath 7:111–118PubMedCrossRef Trakada G, Nikolaou E, Pouli A, Tsiamita M, Spiropoulos K (2003) Endothelin-1 levels in interstitial lung disease patients during sleep. Sleep Breath 7:111–118PubMedCrossRef
Metadata
Title
Should we routinely screen patients with idiopathic pulmonary fibrosis for nocturnal hypoxemia?
Authors
Georgia Pitsiou
Vasilis Bagalas
Afroditi Boutou
Ioannis Stanopoulos
Paraskevi Argyropoulou-Pataka
Publication date
01-05-2013
Publisher
Springer-Verlag
Published in
Sleep and Breathing / Issue 2/2013
Print ISSN: 1520-9512
Electronic ISSN: 1522-1709
DOI
https://doi.org/10.1007/s11325-012-0716-0

Other articles of this Issue 2/2013

Sleep and Breathing 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine